Trump reaches for his pen as long-awaited executive order on drug manufacturing on-shoring finally arrives — reports
President Trump will sign a long-rumored executive order later today that is designed to spur more made-in-the-USA therapies, according to a slate of new reports out Thursday morning.
Drug manufacturing circles have been buzzing about this EO for months now, wondering how Trump plans to require the on-shoring of certain therapies.
According to the Bloomberg report, White House trade adviser Peter Navarro told reporters that the administration will come up with a list of essential medicines Trump wants to have made inside the US. The order will direct government purchasers to buy these essential meds from US suppliers. The reports add that the order relaxes drug safety and environmental regulations to make it happen.
A recent move to back a startup called Phlow with a $354 million grant to build a new facility in Virginia highlighted the administration’s interest in a project that bolsters Trump’s boast about bringing jobs back from overseas. But PhRMA and Big Pharma have been aligned against anything that would disrupt the complex supply chain that’s been built around the world.